From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Pancreatic neuroendocrine tumors (pNETs) are rare, heterogenous neoplasms originating from pancreatic neuroendocrine cells, which regulate hormone secretion and metabolic homeostasis.Pancreatic ...

Abstract: Microscopic examination plays a significant role in the decision making for a reliable diagnosis of digestive neuroendocrine tumors (NETs), an immunohistochemical (IHC) analysis should be ...

Department of Mechanical Engineering, Department of Biological Sciences, and Department of Materials, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53211, and Department of Biomedical ...

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

Table 2. AFT Model to Predict Progression-Free Survival Fig 2. Effect of GETNE-TRASGU (Spanish Group of Neuroendocrine and Endocrine Tumors–Treated With Analog of Somatostatin in ...

Everolimus is a well-established therapeutic option for pancreatic neuroendocrine tumors (pNETs) but resistance is common ... groups and patients were identified as smokers by history (Table 1).

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

The cancer, which develops from the sympathetic nervous system, is the most common type of solid tumor in children outside of the brain. Patients with high-risk neuroblastoma tend to be older than ...